Microsoft Word - Sun Pharma-1QFY2013 - August 13-EDITED.doc - Sun Pharmaceutical - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2012-08-17 03:31:42 Financial ratios Business Earnings before interest taxes depreciation and amortization Sun Pharmaceutical Net profit Profit EV/EBITDA Gross profit DuPont analysis Generally Accepted Accounting Principles Finance Accountancy		Microsoft Word - Sun Pharma-1QFY2013 - August 13-EDITED.doc Add to Reading List Source URL: smartinvestor.business-standard.com Download Document from Source Website File Size: 269,26 KB Share Document on Facebook

	Press Release – 1Q 2009 Results ECS 1Q 2009 NET PROFIT RISES 17.5% Y-o-Y TO $6.9M DESPITE LOWER REVENUE AND GROSS PROFIT MARGIN EASING TO 4.3% FROM 4.9% • DocID: 1t3wf - View Document
	Press Release – 1Q 2011 Results ECS’ 1Q 2011 NET PROFIT RISES 14.9% TO $10.4M, NET MARGIN ALSO UP TO 1.2% IN SEASONALLY SLOWEST QUARTER • 1Q 2011 gross margin improves to 5.1% v/s 4.7% a year ago DocID: 1sPTx - View Document
	FOR IMMEDIATE RELEASE CHINA DISTANCE EDUCATION HOLDINGS LIMITED REPORTS FIRST QUARTER 2012 RESULTS Revenue growth accelerated to 35.8% year-over-year, exceeding guidance Gross profit increased by 57.3% year-over-year DocID: 1sunn - View Document
	Different perspectives on impact David Zetland Leiden University College Minor Entrepreneurship for Society Campus Den Haag ∼ 1 Oct 2015 DocID: 1rqPT - View Document
	BARNES & NOBLE, INC. AND SUBSIDIARIES Consolidated Statements of Operations (In thousands, except per share data) (Unaudited) 13 weeks ended DocID: 1rpBs - View Document